Built-In vs Bolted-On AI: Why Architecture Matters in Life Sciences From Copilot-style assistants to generic AI overlays, many platforms now claim to have ‘groundbreaking’ AI

For regulatory professionals, the idea of cutting hundreds of hours of painstaking work down to just a few clicks has always felt out of reach.

Artificial intelligence is shaping the future of life sciences, offering opportunities to streamline processes, enhance regulatory compliance, and improve operational efficiency. However, despite the potential,

Since founding Generis, James Kelleher has witnessed the company’s transformation from a boutique consultancy into a global leader in content and data management. We caught

With today’s need for speed and efficiency in the life sciences industry, Regulatory Affairs, Pharmacovigilance, Clinical Research, and Quality Management cannot operate as independent islands

Our recent webinar with Remco Munnik, Director at IPERION, a Deloitte Business, Jack Kelleher, Head of Innovation at Generis, and Karolina Rogowska, Head of Marketing